Notable negative changes in Integra LifeSciences Holdings Co (NASDAQ: IART) fundamentals have recently occurred: significant quarterly sales deceleration occurred, the consensus estimate for December, 2024 decreased significantly, and the consensus estimate for December, 2025 decreased significantly.
Important negative changes in Integra LifeSciences Holdings Co (NASDAQ: IART) investment behavior have recently occurred: negative upside/downside volume developed.
In light of these highly negative signals we are reviewing our current Overall Rating of D. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, IART is expected to continue to be an important Value Builder.
Integra LifeSciences Holdings has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Integra LifeSciences Holdings has a good Appreciation Score of 79 but a very low Power Rating of 1, producing the Negative Value Trend Rating.
Recent Price Action
Integra LifeSciences Holdings Co (NASDAQ: IART) stock closed at $20.34 on 8/30/24 after a modest decline of -1.8%. However, trading volume in this decline was unusually low at 51% of normal. The stock is unchanged during the last week and has been extremely weak relative to the market over the last nine months.
Be the first to comment